Retinal vein occlusions in patients taking warfarin*1

Browning, David J.; Fraser, Christina M.

doi:10.1016/j.ophtha.2003.09.047

Cited by 31 publications

(13 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, CVO can still occur in patients being treated with coumadin, suggesting that further studies are needed to establish a better treatment for preventing retinal thrombosis in APS patients. In agreement with this study, the development of retinal vein occlusion was described in 13 patients during anticoagulation with warfarin [26].…”

Section: How To Treat Aps Patients With Retinal Occlusionsupporting

confidence: 90%

Looking Into the Eyes of Patients with Antiphospholipid Syndrome

Yehudai

Shoenfeld

Toubi

2007

Clinic Rev Allerg Immunol

View full text Add to dashboard Cite

Diagnosis of antiphospholipid syndrome (APS) should be considered in all patients with recurrent systemic or ocular thrombosis in the absence of known risk factors. Because of the frequent ocular involvement in APS patients (as many as 80%), an ophthalmologic assessment should become a routine part of the clinical work-up of all patients in whom APS is highly suspected. The presence of isolated ocular thrombosis with persistently increased titers of antiphospholipid antibodies should be considered as definite APS. Ocular involvement in APS is frequently associated with other manifestations of the central nervous system (CNS), such as transient ischemic attack or cerebral vascular events. Diagnostic tools are needed to better establish a diagnosis of retinal vascular thrombosis. The treatment of isolated ocular APS should be based on the same principles as in all patients with systemic APS. Anticoagulation is aimed to prevent recurrent ocular or cerebral thromboses.

show abstract

Section: How To Treat Aps Patients With Retinal Occlusionsupporting

confidence: 90%

Looking Into the Eyes of Patients with Antiphospholipid Syndrome

Yehudai

Shoenfeld

Toubi

2007

Clinic Rev Allerg Immunol

View full text Add to dashboard Cite

show abstract

“…CRVO has been reported in patients receiving chronic, therapeutic levels of warfarin, implying that this medication may be ineffective as prophylaxis. 29,30 Similarly, other vascular agents, including streptokinase, 31 ticlopidine, 32 tissue plasminogen activator, 33 and pentoxifylline, have been studied, 22,23 but they have shown a limited or no benefit. Panretinal photocoagulation has been reported to yield regression of neovascularization in > 90% of cases and to reduce the risk of neovascular glaucoma to 1%.…”

Section: Discussionmentioning

confidence: 99%

“…The pooling of CRVO and BRVO cases may be questionable, because analysis of these entities should ideally be done independently; however, this approach has previously been used in similar surveys. [16][17][18]22,29 The most important limitation of the present study is that it is not a randomized, prospective investigation in which the patients were randomly distributed between a study group and a control group. Indeed, the control group, even if matched for age, gender, RVO type, eye involvement, and BCVA at presentation, was selected retrospectively.…”

mentioning

confidence: 99%

Subcutaneous Nadroparin Calcium in the Treatment of Recent Onset Retinal Vein Occlusion: A Pilot Study

Pinna

Simula

Zinellu

2012

Journal of Ocular Pharmacology and Therapeutics

View full text Add to dashboard Cite

show abstract

“…Salim, et al reported a case of young woman with CRVO due to a hypercoagulable state secondary to FLV mutation, despite systemic anticoagulation therapy [27]. Other authors refer on CRVO occurrence by FLV despite the use of warfarin [28].…”

Section: Factor V Leiden Mutationmentioning

confidence: 99%

Hyper-Homocysteinemia and other Inherited Thrombophilic Factors Inducing Retinal Vein Occlusion. The Employment of Novel Orals Anti-Coagulants is Possible?

Cacciapuoti¹

2017

Int Arch Cardiovasc Dis

View full text Add to dashboard Cite

Retinal vein occlusions in patients taking warfarin*1

Cited by 31 publications

References 16 publications

Looking Into the Eyes of Patients with Antiphospholipid Syndrome

Looking Into the Eyes of Patients with Antiphospholipid Syndrome

Subcutaneous Nadroparin Calcium in the Treatment of Recent Onset Retinal Vein Occlusion: A Pilot Study

Hyper-Homocysteinemia and other Inherited Thrombophilic Factors Inducing Retinal Vein Occlusion. The Employment of Novel Orals Anti-Coagulants is Possible?

Contact Info

Product

Resources

About